Magnesium toxicity from OTC drugs "underestimated," FDAers say in journal article.
This article was originally published in The Tan Sheet
Executive Summary
MAGNESIUM TOXICITY FROM OTC DRUGS "UNDERESTIMATED" by consumers and health care professionals, according to an article by three FDAers in the August issue of the American Medical Association's Archives of Family Medicine. The study, based on adverse event reports collected in FDA's MEDWATCH database, a case report and a literature review, was authored by former OTC Medical Officer Man Fung, MD, Office of OTC Drug Evaluation Director Michael Weintraub, MD, and Medical Review Staff Director Debra Bowen, MD.